[go: up one dir, main page]

Warnatz et al., 1979 - Google Patents

Antibody-dependent cell-mediated cytotoxicity (ADCC) and cell-mediated cytotoxicity (CMC) to HBsAg-coated target cells in patients with hepatitis B and chronic …

Warnatz et al., 1979

View PDF
Document ID
4610954156276099636
Author
Warnatz H
Rösch W
Gerlich W
Gutmann W
Publication year
Publication venue
Clinical and Experimental Immunology

External Links

Snippet

A new technique using HBsAg-coated Chang cells as target cells was developed in order to measure cell-mediated immune reactions to HBsAg. The specificity of cytotoxic reactions was tested in experiments using Chang cells conjugated with human serum albumin …
Continue reading at pmc.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material Not used, see subgroups
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Hansson et al. NK cell-sensitive T-cell subpopulation in thymus: inverse correlation to host NK activity
Guy-Grand et al. Gut injury in mouse graft-versus-host reaction. Study of its occurrence and mechanisms.
Rosenberg et al. Destruction of human lymphoid tissue-culture cell lines by human peripheral lymphocytes in 51Cr-release cellular cytotoxicity assays
Rosenfeld et al. Phenotypic characterisation of a unique non-T, non-B acute lymphoblastic leukaemia cell line
Modlin et al. Suppressor T lymphocytes from lepromatous leprosy skin lesions.
Toews et al. The accessory cell function of human alveolar macrophages in specific T cell proliferation.
Minowada et al. Expression of an antigen associated with acute lymphoblastic leukemia in human leukemia-lymphoma cell lines
Jose et al. Circulating immune complexes in human neuroblastoma: direct assay and role in blocking specific cellular immunity
Hauser et al. Natural killer cell activity in multiple sclerosis.
Schroff et al. Regeneration of T cell subpopulations after bone marrow transplantation: cytomegalovirus infection and lymphoid subset imbalance.
EP0017381A2 (en) Monoclonal antibody to human T cells, method for preparing it, hybrid cell line producing it, therapeutic composition comprising it and diagnostic method using it
Hsu et al. Lymphocytes bearing B-and T-cell markers in patient with lymphosarcoma cell leukemia
Sondel et al. Immunologic Functions of Isolated Human Lymphocyte Subpopulations: III. Specific Allogeneic Lympholysis Mediated by Human T Cells Alone
EP0025722A2 (en) Monoclonal antibody to human cytotoxic and suppressor T cells, and method of preparing it
Hayward et al. Pre-B cell suppression by thymoma patient lymphocytes
Sklenar et al. Association of symptomatic human infection with Toxoplasma gondii with imbalance of monocytes and antigen-specific T cell subsets
Githens et al. Thymic alymphoplasia with XX/XY lymphoid chimerism secondary to probable maternal-fetal transfusion
Akiyama et al. Suppression of the responsiveness of lymphocytes from cancer patients triggered by co-culture with autologous tumor-derived cells.
Warnatz et al. Antibody-dependent cell-mediated cytotoxicity (ADCC) and cell-mediated cytotoxicity (CMC) to HBsAg-coated target cells in patients with hepatitis B and chronic hepatitis (CAH)
Krensky et al. Generation of long-term human cytolytic cell lines with persistent natural killer activity.
Bagnasco et al. Graves' disease: phenotypic and functional analysis at the clonal level of the T-cell repertoire in peripheral blood and in thyroid
Pandolfi et al. Heterogeneity of T-CLL defined by monoclonal antibodies in nine patients
Yu Human lymphocyte subpopulations: Giant SRBC rosettes
Wood et al. Comparison of immune responsiveness in mice after single or multiple donor-specific transfusions.
Garnis et al. Surface markers of small lymphocytes appearing in the mouse Ehrlich ascites tumour, host spleen and blood